Brucella neotomae Infection in Humans, Costa Rica
Marcela Suárez-Esquivel, Nazareth Ruiz-Villalobos, César Jiménez-Rojas, Elías Barquero-Calvo, Carlos Chacón-Díaz, Eunice Víquez-Ruiz, Norman Rojas-Campos, Kate S. Baker
1, Gerardo Oviedo-Sánchez, Ernesto Amuy, Esteban Chaves-Olarte, Nicholas R. Thomson, Edgardo Moreno, and Caterina Guzmán-Verri
Author affiliations: Universidad Nacional, Heredia, Costa Rica (M. Suárez-Esquivel, N. Ruiz-Villalobos, C. Jiménez-Rojas, E. Barquero-Calvo, E. Víquez-Ruiz, E. Moreno, C. Guzmán-Verri); Universidad de Costa Rica, San José, Costa Rica (E. Barquero-Calvo, C. Chacón-Díaz, N. Rojas-Campos, G. Oviedo-Sánchez, E. Chaves-Olarte, E. Moreno, C. Guzmán-Verri); Wellcome Trust Sanger Institute, Hinxton, UK (K.S. Baker, N.R. Thomson); Caja Costarricense del Seguro Social, Puntarenas, Costa Rica (E. Amuy)
Main Article
Table
Differential biochemical profile of Brucella isolates from 2 men with neurobrucellosis, Costa Rica, 2008 and 2011
Analysis
|
bneohCR1
|
bneohCR2
|
Biochemical tests |
|
|
Oxidase |
- |
– |
Citrate utilization |
– |
– |
Nitrate reduction |
+ |
+ |
CO2 required |
– |
– |
H2S production |
+ |
+ |
Urease activity, h
|
0–0.5+
|
0–0.5+
|
Growth in presence of dyes |
|
|
Thionin 20 μg/mL |
– |
– |
Basic fuchsin 20 μg/mL
|
–
|
–
|
Agglutination using monospecific serum |
|
A |
+ |
+ |
M |
– |
– |
Main Article
Page created: July 11, 2017
Page updated: July 11, 2017
Page reviewed: July 11, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.